TRILLIANT HEALTH RESEARCH

Research

Timely analysis on trends shaping the health economy, released weekly.

Timely trend analysis. Free in your inbox.

Receive weekly studies from Trilliant Health.

Featured Research

More Than Half of GLP-1 Patients Have a Diagnosis Associated with a Newly Approved or Investigational Indication

Read the Study

Filter by Type...StudiesFundamentalsStrategy

Studies

February 04, 2024

Local Analysis of Nonalcoholic Steatohepatitis Underscores Need for Targeted Treatment

Despite estimates of adults with nonalcoholic fatty liver disease, there are no approved medicines to treat the condition and research is limited.

Katie Patton • Austin Miller • Sanjula Jain, Ph.D.

Studies

January 14, 2024

Part 2: Harnessing Price Transparency Data to Analyze True Cost of Care

Combining data about negotiated rates, utilization and provider info enables market-level strategic insights and optimization of healthcare costs.

Katie Patton • Sanjula Jain, Ph.D. • Matt Ikard • Jim Browne

Studies

January 07, 2024

Part 1: The Economic Framework of Price Transparency Data

Understanding the identity of services rendered by every provider is foundational to connecting a negotiated rate to a specific provider and location.

Katie Patton • Matt Ikard • Jim Browne • Sanjula Jain, Ph.D.

Studies

December 17, 2023

The Market Rate Has Been Revealed, and It Is Lower Than You Think

Our research reveals that rates vary widely within and among markets for the same healthcare services, even high-volume preventive procedures.

Katie Patton • Sanjula Jain, Ph.D. • Matt Ikard

Studies

September 10, 2023

GLP-1 Utilization in New York City Is Not Correlated with Clinical Indication

GLP-1s can revolutionize clinical treatment of obesity and diabetes, but current utilization patterns are not correlated with clinical disease.

Sarah Millender • David Taylor • Allison Oakes, Ph.D. • Austin Miller

Studies

August 13, 2023

The Cell and Gene Patient Journey Is Determined by Access to Treatment Sites

Implementing comprehensive patient support programs could address barriers, including travel costs, compliance challenges and care coordination.

Sanjula Jain, Ph.D.

Studies

July 23, 2023

Employers Have a Critical Role in Containing U.S. Healthcare Spending

Health plan price transparency should compel health economy stakeholders to compete based on cost, quality and access, which are elements of value.

Katie Patton • Sanjula Jain, Ph.D.

Studies

June 18, 2023

National Distribution Reveals Variation in Quality, Financial and Competitive Performance Among Renowned U.S. Hospitals

Accounting for factors such as services rendered, bed size and market characteristics is critical for identifying true hospital peers.

Katie Patton • Sanjula Jain, Ph.D.

Studies

May 21, 2023

While Originally Intended for Consumers, Health Plan Price Transparency Will Ultimately Promote Value-Based Competition

Challenges in leveraging health plan price transparency data, including errors in cardiology rates, limit accessibility and analysis for data experts.

Katie Patton • Sanjula Jain, Ph.D. • Matt Ikard • Colin Macon

Interested in citing our research? Please follow this guide.

Citation Guide